Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid.
about
Chemical Swarming: Depending on Concentration, an Amphiphilic Ruthenium Polypyridyl Complex Induces Cell Death via Two Different MechanismsCellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.Confocal fluorescence microscopy studies of a fluorophore-labeled dirhodium compound: visualizing metal-metal bonded molecules in lung cancer (A549) cells.Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.Enhanced Cytotoxicity through Conjugation of a "Clickable" Luminescent Re(I) Complex to a Cell-Penetrating LipopeptideModifying charge and hydrophilicity of simple Ru(II) polypyridyl complexes radically alters biological activities: old complexes, surprising new tricks.Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands.Phosphorescent biscyclometallated iridium(III) ethylenediamine complexes functionalised with polar ester or carboxylate groups as bioimaging and visualisation reagents.Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.Unique antitumor property of the Mg-Ca-Sr alloys with addition of Zn.Di-heterometalation of thiol-functionalized peptide nucleic acidsA redox responsive, fluorescent supramolecular metallohydrogel consists of nanofibers with single-molecule width.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.Ruthenium polypyridine complexes combined with oligonucleotides for bioanalysis: a review.Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.Nanostructures for NIR light-controlled therapies.Insights into the in vitro Anticancer Effects of Diruthenium-1.Biological processing of dinuclear ruthenium complexes in eukaryotic cells.Ruthenium(ii) complexes with dppz: from molecular photoswitch to biological applications.Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.Bis(dipyridophenazine)(2-(2'-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) hexafluorophosphate: a lesson in stubbornness.A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection.A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complex.Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.Synthesis, characterization, and DNA binding, photocleavage, cytotoxicity, cellular uptake, apoptosis, and on-off light switching studies of Ru(II) mixed-ligand complexes containing 7-fluorodipyrido[3,2-a:2',3'-c]phenazine.9-(4-Dimethylaminophenyl)benzo[b]quinolizinium: a near-infrared fluorophore for the multicolor analysis of proteins and nucleic acids in living cells.The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Ruthenium bistridentate complexes with non-symmetrical hexahydro-pyrimidopyrimidine ligands: a structural and theoretical investigation of their optical and electrochemical properties.Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition.Theranostic TEMPO-functionalized Ru(ii) complexes as photosensitizers and oxidative stress indicators.Structures and anti-cancer properties of two binuclear copper complexes.
P2860
Q28822145-AEB2CA36-86F5-4457-97A3-15FCD1C9CCC6Q33670035-606E8BF7-65C9-4CFC-8A3C-52F4336933A7Q33776520-891116CC-17EA-4CD3-A027-24343D1D7407Q33862903-92C4CFAC-8260-4DB8-9AB1-784510AD6EEFQ33889086-6F43B442-84F3-4FE7-95FF-CD22F0D262BAQ34293548-D0D8EAA7-4C51-410E-BDFF-AA2BB09E75ABQ34331245-E77377BB-69EC-449B-9A8F-A89C0FA7695CQ35529827-60443351-8FE0-4723-9EFA-701AF789B37BQ35804259-FFA12C0C-E26C-4DE2-A0F2-3F9F0E9ACB60Q36610950-D5251170-BB07-4C44-BA2F-B1AE3B8AF5E8Q36846188-AD0977AF-41FE-412D-91CD-B5AE7F55E51EQ37136635-22C70F2D-5570-4E5C-A07E-5957FE010E1CQ38199383-3116B711-6E47-4306-92D9-00914BCF97EAQ38239356-CDC56211-D18F-4640-8C15-021775CCE53CQ38539464-A82F309E-2509-4BC5-AE5A-738FBFFA16B0Q38704083-EFBD4B9B-CA79-400B-A974-5F537AA18845Q38735217-C7F718C4-6953-43EF-95AA-E6D8AC1867CBQ38748878-83C2967C-AF7C-47B7-96B7-6D2C83AAD1A1Q38750151-871A3169-454A-4D31-A1C0-3CB5C1870092Q38756115-EB2A58D4-6B23-463C-9CF5-CB659EC73B47Q38899882-6C200415-46C0-4D76-890E-E34796F7536DQ38941173-30AF4142-A48F-4EDC-9344-30D7ED55BB00Q38942097-FDC17664-08F4-4205-873A-FF32EFCF831FQ38962540-0260909D-FFD7-4AE2-BF13-14D979D80DDAQ38969205-4B7C52CA-39E4-4062-981E-BF1DD398FD50Q39018867-20D525ED-ECB2-4D3D-B775-18CCE12F6F54Q39026748-F5C2EAB9-A2B9-45EF-91AF-0C92C8CF12DEQ39030454-3EDA46BB-771C-4651-A04E-678553E657F1Q39052398-4410738C-5FE7-4210-ADFD-6D22E5C83427Q39103148-21F1A975-2C42-415C-B864-9AC5615D10F9Q39127188-901D4EF1-3520-4279-8C9E-5C1E74BA7108Q39148021-59524A5C-49DD-4C11-8D77-2E202AA7DA39Q39182036-B89D427D-673B-4581-B40A-CBB047FB43AEQ39187880-68A4DA65-CC81-4A3F-8A62-ACF487DEED91Q39400527-0E802F79-CCAC-4CD7-867E-955C06384102Q39582838-305EDAF5-AF87-4572-B8C3-B376AA1798CFQ39869933-D34573C7-14DE-425D-8E94-70E62B9F8974Q41207594-C000E4B3-8323-4E87-AA8D-5F2922341C78Q43483494-0AC358CE-E468-4B7D-873A-1EB67180F603Q44452152-760A6372-FFF8-43C9-9545-9FA42EC7C1E8
P2860
Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Molecular and cellular characterization of the biological effects of ruthenium
@nl
Molecular and cellular charact ...... -pyrimidine-4-carboxylic acid.
@en
type
label
Molecular and cellular characterization of the biological effects of ruthenium
@nl
Molecular and cellular charact ...... -pyrimidine-4-carboxylic acid.
@en
prefLabel
Molecular and cellular characterization of the biological effects of ruthenium
@nl
Molecular and cellular charact ...... -pyrimidine-4-carboxylic acid.
@en
P2093
P356
P1476
Molecular and cellular charact ...... -pyrimidine-4-carboxylic acid.
@en
P2093
Anna Leonidova
Cristina Mari
Gilles Gasser
Julia Schur
Leone Spiccia
Stefano Ferrari
Tanmaya Joshi
Vanessa Pierroz
P304
20376-20387
P356
10.1021/JA307288S
P407
P577
2012-12-11T00:00:00Z